According to research presented by Dr. Elena Toschi from Harvard Medical School, a more significant difference between Hba1c and GMI was associated with a higher risk of low blood glucose.
According to research presented by Dr. Andrea Dehn-Hindenberg from the Hannover Medical School in Germany, mothers in children with diabetes experience many challenges in their occupational settings.
In patients with type 2 diabetes mellitus, composite mortality/HHF was significantly lower in patients taking metformin versus those taking sulfonylurea.